XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Dec. 31, 2017   12,621,781      
Balance at Dec. 31, 2017 $ 47,495 $ 2 $ 150,424 $ (103,066) $ 135
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (12,025)     (12,025)  
Restricted stock (in shares)   177,208      
Restricted stock $ 3,186 $ 1 3,185    
Stock option exercise (in shares) 14,213 14,213      
Stock option exercise $ 410   410    
Issuance of common stock, net of issuance cost (in shares)   1,725,000      
Issuance of common stock, net of issuance cost 43,424 $ 1 43,423    
Other comprehensive income (758)       (758)
Balance (in shares) at Dec. 31, 2018   14,538,202      
Balance at Dec. 31, 2018 81,732 $ 4 197,442 (115,091) (623)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (13,731)     (13,731)  
Acquisition consideration (in shares)   245,352      
Acquisition consideration 10,000   10,000    
Restricted stock (in shares)   145,153      
Restricted stock $ 2,603   2,603    
Stock option exercise (in shares) 38,920 38,921      
Stock option exercise $ 1,141   1,141    
Issuance of common stock, net of issuance cost (in shares)   1,755,500      
Issuance of common stock, net of issuance cost 59,996   59,996    
Other comprehensive income $ 620       620
Balance (in shares) at Dec. 31, 2019 16,723,128 16,723,128      
Balance at Dec. 31, 2019 $ 142,361 $ 4 271,182 (128,822) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (32,944)     (32,944)  
Acquisition consideration (in shares)   1,025,782      
Acquisition consideration 39,388   39,388    
Restricted stock (in shares)   162,125      
Restricted stock $ 6,196   6,196    
Stock option exercise (in shares) 53,270 53,270      
Stock option exercise $ 1,650   1,650    
Issuance of common stock, net of issuance cost (in shares)   1,595,986      
Issuance of common stock, net of issuance cost 70,207 $ 1 70,206    
Other comprehensive income $ 7,910       7,910
Balance (in shares) at Dec. 31, 2020 19,560,291 19,560,291      
Balance at Dec. 31, 2020 $ 234,768 $ 5 $ 388,622 $ (161,766) $ 7,907